The increasing incidence of infectious and chronic diseases has resulted in sustained growth and demand for sample and specimen testing to keep pace with the upsurge in market growth. In a field characterized by ever-evolving technology and emergent testing assays, clinical diagnostics professionals require nimble, adaptable spaces; staffing; and operational models capable of accommodating improved speed-to-market of leading-edge equipment platforms and esoteric tests.

Join an exclusive, Flad-hosted virtual roundtable event featuring industry-leading experts – Theran Myers from Exact Sciences; Robert Roggeman from Quest Diagnostics; Richie Seaberg from Northwell Health; James Zehnder, MD, from Stanford University School of Medicine; and senior principals and planners from Flad – as they discuss this quickly changing clinical diagnostics market. Panelists will look at the future of the clinical diagnostic testing industry — exploring enterprise operational challenges and where investments are being made, how organizations can be more proactive, and where trends are pointing.
  • Welcome and Introductions
  • Clinical Diagnostics Panel Discussion
  • Q&A
  • 1632761019-d7ecedb29fc4530a
    Theran Myers
    Director of Laboratory Systems Development, Exact Sciences

    With deep and diverse expertise in laboratory science, Theran’s specialties include medical microbiology and immunology, molecular genetics, and DNA extraction optimization for HPV and STI test development. More than nine years ago, Theran joined Exact Sciences to support laboratory testing for the Cologuard clinical trial. He has been involved in designing and optimizing the clinical labs that have scaled Cologuard from 0 to millions of reported results per year. He continues to support Cologuard process optimization as well as new test deployment and optimization at Exact Sciences Laboratories.

  • 1632760988-fcd5ef137131a61b
    Robert Roggeman, MT (ASCP), MBA
    Senior Director Program Management, Quest Diagnostics

    As a Licensed Medical Technologist at Quest Diagnostics, Robert has been the Program Director for managing the design, construction, fit-out, and start-up of Quest’s new Lab of the Future in Clifton, NJ; ensuring the laboratory opened on schedule despite the impact of the COVID-19 pandemic. Prior to joining Quest, Robert served as CEO and Vice President of Testing for the American Red Cross where he participated in multiple lab build-outs and redesign efforts and coordinated the consolidation of laboratory operations into two of the largest blood screening laboratories in the United States. Robert has also been a keynote speaker in symposiums in China and Latin America on laboratory consolidation and quality performance in blood screening laboratories.

  • 1632857889-0dd684d4d0949dea
    Richie Seaberg, MT (ASCP)
    Director of Business Services/Administrative Director, Northwell Health

    Richie is a dedicated laboratorian focused on developing new facilities, incorporating new hardware, and developing new methods that will enhance the patient and associate experience. He firmly believes that achieving these goals requires maintaining a strong vision of the future, embracing advancements in IT, preparing for potential contingencies, and working collaboratively within teams.

  • 1632760973-b66f6b0cc11c57ed
    James L. Zehnder, MD
    Professor of Pathology and Medicine (Hematology), Director of Clinical Pathology, Department of Pathology, Stanford University School of Medicine

    Trained in internal medicine, hematology and oncology, Dr. Zehnder joined the pathology department at Stanford University as director of the coagulation lab in 1994. At the time, factor V Leiden, the most common inherited mutation causing blood clotting risk, was discovered, which prompted the launch of Stanford’s molecular pathology laboratory. Since 2016, Dr. Zehnder has served as the director of clinical pathology. In addition, he continues to see hematology patients in clinic and attends on the hospital hematology consult service.

  • 1631822464-ed64a875302ba5c0
    Paul Hansen, AIA, LEED AP
    Principal, Flad Architects
    Event Moderator

    Paul's years of leading and managing projects that support science discovery, development, and manufacturing have given him unique insights into the questions asked by clients and their probable motivations – the questions behind the questions. Understanding their methods, he can find the ways in which their business objectives and the solutions crafted by the design team align. As a former client, project leader, and client advocate with extensive experience from multiple perspectives, he's a calming influence – listening, providing counsel, and delineating solutions that enable business, helping advance conversations to positive outcomes.

  • 1631822441-7005c988eb0535bf
    Cole Brunson, AIA, LEED AP
    Principal, Science Planner, Flad Architects

    As an architect and lab planner, Cole has worked on large, complex projects including pharmaceutical, process manufacturing, and research laboratories, always with an eye toward spaces that are functional, flexible, efficient, and safe. Adept at solving the puzzles inherent in laboratory planning, he's also a good listener, a vital skill in the process of understanding a client's challenges so that options can be developed, presented, and recommended.

  • 1631822418-f45614b8cdecb51a
    Chad Zuberbuhler, Assoc. AIA
    Principal, Science Planner, Flad Architects

    A planner who works with project teams to support the development of facility design and program solutions, Chad contributes to program conception and planning of laboratories, including mechanically intensive support areas, initial development and drawing of plans/elevations, facility process flows, and coordination of details and documentation. He knows that, above all, laboratory spaces need to function well, so his primary goal is to understand how the design team can help facilitate the client’s mission and optimize the lab space.